Breastfeeding Self-Management for Nipple and Breast Pain (BSM)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03392675 |
Recruitment Status :
Completed
First Posted : January 8, 2018
Last Update Posted : March 11, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Breastfeeding Breast Pain | Behavioral: Self-monitoring of BF and intervention | Not Applicable |
Breastfeeding (BF) is one of the most important early determinants of infant health and development. Duration of BF is significantly related to reduced incidence of infantile respiratory and gastrointestinal tract infections, obesity and asthma. However, over 35% of mothers cease exclusive BF during the first 6 weeks due to nipple and breast pain. While 90% of mothers report acute nipple and breast pain during the first week of BF initiation, approximately 30% will experience persistent pain (>10 days). Due to the significant impact of nipple and breast pain on BF duration, pain is a significant barrier for achieving public health outcomes.
The following pilot project will test the feasibility of a Breastfeeding Self-Management (BSM) Intervention on BF outcomes in mothers with nipple and breast pain. In addition, the proposed study will provide a preliminary examination of genetic, psychological and somatosensory factors that predict nipple and breast pain and possibly, early cessation of BF.
Individual factors, including genetic polymorphisms of pain sensitivity genes and the individual's interpretation of pain can influence pain facilitation or inhibition at the molecular level of pain processing. Moreover, maternal anticipation of pain may increase pain catastrophizing, perceived stress and reactivity contributing to increased peripheral and central sensitivity. Identifying strategies to increase mothers' BF knowledge, pain self-efficacy and self-regulation skills could lead to increased SM behaviors. Therefore, this pilot study was designed to target pain SM process factors (self-monitoring, knowledge of breast care, BF self-efficacy, pain self-efficacy, and problem solving) relevant to mothers who experience pain during BF. The overarching goal of this program of research is to improve nipple and breast pain SM in BF mothers and enhance their BF self-efficacy to achieve their BF goals.
The proposed study will address a major barrier of BF duration by identifying factors that contribute to nipple and breast pain. The proposed SM intervention will specifically target pain information, pain self-efficacy and problem-solving as central components of the SM process. In addition, the investigators will examine the influence of peripheral and central sensitivity and frequency of catechol-O-methyltransferase (COMT) single-nucleotide polymorphisms (SNPs), on SM process and outcome variables over time to gain knowledge about the precise influence of the molecular context of pain on risk of nipple and breast pain and BF outcomes.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 65 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Participant) |
Masking Description: | Using a stratified and blocked randomization scheme. |
Primary Purpose: | Supportive Care |
Official Title: | Promoting Self-Management of Breast and Nipple Pain in Breastfeeding Women |
Actual Study Start Date : | April 24, 2017 |
Actual Primary Completion Date : | November 6, 2017 |
Actual Study Completion Date : | November 7, 2017 |

Arm | Intervention/treatment |
---|---|
Experimental: Self-monitoring of BF and intervention
Self-monitoring and regulation skills will be provided to mothers at discharge. Aside from daily diaries outlining, infant feeding behaviors and pain, mothers will be instructed to watch several 5-minute video modules to assist with self-management of breast and nipple pain. These videos include: pain neurophysiology; non-pharmacological strategies; common BF issues and intervention; catastrophizing; stress reactivity; deep breathing; guided imagery and support (informational and instrumental). These mothers will also be asked to complete study questionnaires and measures at specified time points.
|
Behavioral: Self-monitoring of BF and intervention
Self-Monitoring: At discharge, mothers will complete daily diaries for self-monitoring to stimulate cognitive reframing on the occurrence, duration, and characteristics of nipple and breast pain, infants' latch and sucking pattern, positioning, length of each BF session, and the MAIBB. Self-Regulation: To support self-regulation skills, mothers will be provided with several 5-minute video modules on pain and BF pain SM with additional resources links. After discharge mother will receive text message from a nurse 2X/week for BF support. Mothers may text the nurse for emergent BF support. |
No Intervention: Control
Usual care and asked to complete measures at follow-up time points.
|
- Pain Sensitivity [ Time Frame: Baseline ]Quantitative sensory testing
- Genetic variations in COMT [ Time Frame: Baseline ]Pain susceptibility SNPs genotyping related to breastfeeding related breast and nipple pain.
- Increased duration of breastfeeding [ Time Frame: Week 1, 2 and 6 ]With self-management of breast and nipple pain

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 45 Years (Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Have just given birth (<48 hours)
- Intention to breastfeed for 6 weeks
- Has daily access to a computer with internet
- Access to a phone
- Read and speak English
- Delivered a healthy singleton infant born >37 weeks gestational age
Exclusion Criteria:
- Infants with congenital anomalies
- Mothers with major mental health issues (i.e Schizophrenia, Mania, Bipolar Disorder)
- Complications during delivery requiring intervention
- Mothers with major health issues that are not associated with pregnancy as determined by principal investigator (i.e. infection illness such as HIV+, hepatitis, diabetes, history of seizures, current diagnosis of cancer).

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03392675
United States, Connecticut | |
UConn Health | |
Farmington, Connecticut, United States, 06030 | |
Manchester Memorial Hospital | |
Manchester, Connecticut, United States, 06040 |
Principal Investigator: | Ruth Lucas, PhD, RN | University of Connecticut |
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | University of Connecticut |
ClinicalTrials.gov Identifier: | NCT03392675 |
Other Study ID Numbers: |
H16-321 5P20NR016605-02 ( U.S. NIH Grant/Contract ) |
First Posted: | January 8, 2018 Key Record Dates |
Last Update Posted: | March 11, 2021 |
Last Verified: | March 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | All of the individual participant data that are part of National Institute of Nursing Research (NINR) designated common data elements collected during the trial, after de-identification have been submitted to NIH repository at the Common Data Repository for Nursing Science (cdRNS). Data can be accessed by directly submitting requests at that website. When will data be available (start and end dates)? Immediately. No end date. With whom? Anyone who wishes to access the data and creates an account on cdRNS.nih.gov. By what mechanism will data be made available? Data are available at cdRNS.nih.gov |
Time Frame: | within 2 years |
Access Criteria: | Requests will be submitted through the cdRNS website. |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Breast and Nipple Pain Quantitative Sensory Testing Genotyping Breastfeeding |
Mastodynia Pain Neurologic Manifestations |